Aglaia Oncology Funds
Netherlandsaglaia-oncology.com
Overview
Aglaia Oncology Funds is a Dutch venture capital firm that invests in early-stage oncology drug development companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ORCA Therapeutics | Sep 2024 | VC Round | Co-investor |
| Sapreme Technologies BV | Oct 2021 | Series A | Lead |
| InteRNA Technologies | Feb 2021 | Series B Extension | Co-investor |
| MIMETAS | Apr 2018 | Series B | Co-investor |
| ORCA Therapeutics | Apr 2016 | VC Round | Co-investor |
Key People
Karl Rothweiler
Founder, Founding Investor, Member Of The Supervisory Board
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
